Group A beta-hemolytic streptococcus (GABHS) infections are implicated in neuropsychiatric disorders associated with an increased expression of repetitive stereotyped movements. Anti-streptococcus IgG presumably cross-reacts with elements on basal ganglia cells, modifies their function, and triggers symptoms. IgM may play a unique role in precipitating behavioral disturbances since variations in cortico-striatal activity occur in temporal congruity with peak IgM titers during an orchestrated immune response. We discovered in Balb/c mice that single subcutaneous injections of mouse monoclonal IgM antibodies to streptococcus group A bacteria induce marked dose-dependent increases in repetitive stereotyped movements, including head bobbing, sniffing, and intense grooming. Effects were antibody-and antigen-specific: anti-streptococcus IgG stimulated ambulatory activity and vertical activity but not these stereotypies, while anti-KLH IgM reduced activity. We suggest that anti-streptococcus IgM and IgG play unique roles in provoking GABHS-related behavioral disturbances. Paralleling its stereotypy-inducing effects, anti-streptococcus IgM stimulated Fos-like immunoreactivity in regions linked to cortico-striatal projections involved in motor control, including subregions of the caudate, nucleus accumbens, and motor cortex. This is the first evidence that anti-streptococcus IgM antibodies induce in vivo functional changes in these structures. Moreover, there was a striking similarity in the distributions of anti-streptococcus IgM deposits and Fos-like immunoreactivity in these regions. Of further importance, Fca/l receptors, which bind IgM, were present-and co-localized with anti-streptococcus IgM in these structures. We suggest that anti-streptococcus IgM-induced alterations of cell activity reflect local actions of IgM that involve Fca/l receptors. These findings support the use of anti-streptococcus monoclonal antibody administration in Balb/c mice to model GABHS-related behavioral disturbances and identify underlying mechanisms.
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Introduction
Group A beta-hemolytic streptococcus (GABHS) infections are implicated in neuropsychiatric disorders associated with an increased expression of repetitive behaviors, including motor stereotypies such as head shaking, sniffing, and touching movements (see Murphy and Pichichero, 2002; Church et al., 2003; Murphy et al., 2004 Murphy et al., , 2010 Snider and Swedo, 2004; Leslie et al., 2008) . Studies have shown that children suffering from pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), Tourette syndrome (TS), Sydenham's Chorea (SC), obsessive-compulsive disorder (OCD), and other tic disorders are twice as likely to have had a streptococcus infection preceding diagnosis (Mell et al., 2005 ; see also Leslie et al., 2008) . Of further importance, anti-streptococcal antibody titers have been positively correlated with clinical severity in patients suffering from TS, autism spectrum disorder, and other disorders involving repetitive stereotyped movements (Vojdani et al., 2002) . Tic disorders and other psychiatric disorders are often co-morbid; for example, about half of TS patients also display OCD (Albin and Mink, 2006) .
Abnormalities in cortico-striato-thalamo-cortical (CSTC) circuits are thought to underlie symptom expression. In GABHS-related disorders, anti-neuronal antibodies are thought to cross-react with elements on cells within these circuits, particularly in the basal ganglia (Kiessling et al., 1993; Kirvan et al., 2006; Leckman et al., 2010) . For example, increases in antibodies directed against elements in the caudate nucleus have been observed in patients suffering from SC or acute rheumatic fever (Husby et al., 1976;  
